These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2970641)

  • 1. Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.
    Oh-Ishi T; Goldman CK; Misiti J; Waldmann TA
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6478-82. PubMed ID: 2970641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of interleukin 2 with its receptor in the generation of suppressor T cells in antigen-specific and antigen-nonspecific systems in vitro.
    Oh-Ishi T; Goldman CK; Misiti J; Waldmann TA
    Clin Immunol Immunopathol; 1989 Sep; 52(3):447-59. PubMed ID: 2547539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
    J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes.
    Baroja ML; Ceuppens JL
    J Immunol Methods; 1987 Apr; 98(2):267-70. PubMed ID: 3033083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of CD4-positive suppressor T cells from mixed lymphocyte cultures in the presence of interleukin 2 receptor antibody TU69. An in vitro model for transplantation tolerance induction.
    Schneider EM; Pawelec G; Shi LR; Bühring HJ; Wernet P
    Transplantation; 1987 Aug; 44(2):295-302. PubMed ID: 2957831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.
    Rubin LA; Kurman CC; Biddison WE; Goldman ND; Nelson DL
    Hybridoma; 1985; 4(2):91-102. PubMed ID: 2408992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA; Goldman CK; Robb RJ; Depper JM; Leonard WJ; Sharrow SO; Bongiovanni KF; Korsmeyer SJ; Greene WC
    J Exp Med; 1984 Nov; 160(5):1450-66. PubMed ID: 6092511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
    Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 receptor blockade by anti-Tac antibody inhibits IFN-gamma induction.
    Croll AD; Wilkinson MF; Morris AG
    Cell Immunol; 1985 Apr; 92(1):184-9. PubMed ID: 3000625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.
    Tsudo M; Kozak RW; Goldman CK; Waldmann TA
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9694-8. PubMed ID: 3099289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T3-Ti receptor triggering of T8+ suppressor T cells leads to unresponsiveness to interleukin-2.
    Bensussan A; Acuto O; Hussey RE; Milanese C; Reinherz EL
    Nature; 1984 Oct 11-17; 311(5986):565-7. PubMed ID: 6237264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2].
    Cornaglia-Ferraris P; Baffico M
    Boll Ist Sieroter Milan; 1985; 64(6):471-4. PubMed ID: 3938289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal anti-tac antibody may interfere with receptor binding of interleukin 2.
    Taniguchi N; Miyawaki T; Yachie A
    Lymphokine Res; 1982; 1(4):107-12. PubMed ID: 6097775
    [No Abstract]   [Full Text] [Related]  

  • 17. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
    Tan P; Anasetti C; Martin PJ; Hansen JA
    J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
    Bich-Thuy LT; Dukovich M; Peffer NJ; Fauci AS; Kehrl JH; Greene WC
    J Immunol; 1987 Sep; 139(5):1550-6. PubMed ID: 3040856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte function in human bone marrow. I. Characterization of two T cell populations regulating immunoglobulin secretion.
    Mills GB; Ledgley CJ; Hibi T; White D; Lam P; Dosch HM
    J Immunol; 1985 May; 134(5):3036-41. PubMed ID: 3156927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
    Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.